| CTRI Number |
CTRI/2024/11/076386 [Registered on: 08/11/2024] Trial Registered Prospectively |
| Last Modified On: |
08/11/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Other |
|
Public Title of Study
|
Study to evaluate the effect of Kshara basti and Churna basti in the management of Amavata |
|
Scientific Title of Study
|
A Comparative clinical study to evaluate the effect of Kshara basti and Churna basti in the management of Amavata |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ravikumar M |
| Designation |
P G scholar |
| Affiliation |
Muniyal institute of Ayurveda medical sciences manipal |
| Address |
Muniyal institute of Ayurveda medical sciences manipal
Panchakarma OPD-Room No-4
34 C Shivalli industrial area manipal
Udupi KARNATAKA 576104 India |
| Phone |
9980952358 |
| Fax |
|
| Email |
raviamrita.kumar9@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sudarshana |
| Designation |
Professor and HOD |
| Affiliation |
Muniyal institute of Ayurveda medical sciences manipal |
| Address |
Muniyal institute of Ayurveda medical sciences manipal
Panchakarma OPD Roon No - 4
34 C Shivalli industrial area manipal
Udupi KARNATAKA 576104 India |
| Phone |
9481227666 |
| Fax |
|
| Email |
drsalevoor@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Ravikumar M |
| Designation |
P G scholar |
| Affiliation |
Muniyal institute of Ayurveda medical sciences manipal |
| Address |
Muniyal institute of Ayurveda medical sciences manipal
Panchakarma OPD Roon No-4
34 C Shivalli industrial area manipal
Udupi KARNATAKA 576104 India |
| Phone |
9980952358 |
| Fax |
|
| Email |
raviamrita.kumar9@gmail.com |
|
|
Source of Monetary or Material Support
|
| Muniyal institute of Ayurveda Medical sciences Maniopal
34C Shivalli industrial area manipal Karnataka - 576104 |
|
|
Primary Sponsor
|
| Name |
Muniyal institute of Ayurveda |
| Address |
34 C Shivalli industrial area manipal, Karnataka - 576104 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Ravikumar M |
Muniyal institute of Ayurveda |
Panchakarma OPD ground floor
34 C Shivalli industrial area Manipal Udupi KARNATAKA |
9980952358
raviamrita.kumar9@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Muniyal institute of Ayurveda Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:M049||Autoinflammatory syndrome, unspecified. Ayurveda Condition: AMAVATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | Yoga basti | (Procedure Reference: Chakradatta, Procedure details: kshara basti will be given in Yoga basti pattern. initially sthanika abhyanga will be given then basti is adminisered. total duration of procedure 45 min ) (1) Medicine Name: Kshara basti, Reference: chakradatta, Route: Rectal, Dosage Form: Not Applicable, Dose: 450(ml), Frequency: od, Duration: 3 Days | | 2 | Comparator Arm | Procedure | - | anuvAsana-bastiH, अनà¥à¤µà¤¾à¤¸à¤¨-बसà¥à¤¤à¤¿à¤ƒ | (Procedure Reference: Bhaishajya Ratnavali, Procedure details: Anuvasana basti will be given in Yoga basti pattern. initially sthanika abhyanga will be given then basti is adminisered. total duration of procedure 45 min ) (1) Medicine Name: Bhrihat saindhavadi taila, Reference: Bhaishajya Ratnavali, Route: Rectal, Dosage Form: Taila, Dose: 72(ml), Frequency: hs, Duration: 5 Days |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
patients with classical symptoms of Amavata
patients willing to participate in the study |
|
| ExclusionCriteria |
| Details |
patients with any uncontrolled systemic disorders. pregnant and lactating women. patients contraindicated for Basti karma |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| pain and swelling |
pain and swelling gets reduced by 1 week of treatment |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduction in Swelling |
Swelling gets reduced by 1 week |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
19/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="25" Months="9" Days="23" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
it is a comparative clinical study with pre and post test design where in a 40 recruited participants will be assigned to a two groups group A and group B with the sample size of 20 participants each suffering from amavata, will be subjected for the intervention , and the assessment will be made on 0 th day and after the completion of their treatment on the 8 th day, followed by two weeks follow up. |